TKIs in CLL: an overview

The use of tyrosine kinase inhibitors (TKIs) in chronic lymphocytic leukemia (CLL) is expanding. In this video, recorded at the 23rd Congress of the European Hematology Association (EHA) 2018, held in... Author: VJHemOnc Added: 07/18/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts